pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
Oct 20, 26
Recon: AZ, Oracle partner for AI-powered clinical trials; FDA approves Haemonetics vascular closure system
raps
Oct 19, 26
Sanofi breaks ground on insulin plant after securing German government support
biospace
Oct 19, 26
Opinion: I was a Theranos whistleblower. In ‘You Can See Everything,’ Elizabeth Holmes is still lying
stat
Oct 19, 26
Disc’s once-spurned rare disease drug to get a second chance at approval
biopharma dive
Oct 19, 26
FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
fda press
Oct 19, 26
STAT+: The umpires getting rich off surprise medical bills, and MLB job lock
stat
Oct 19, 26
Merck KGaA makes noise in hematology with $1.1B Silence buy
biospace
Oct 19, 26
STAT+: China moves to restrict foreign biotech acquisitions
stat
Oct 19, 26
Roche returns to Hansoh with broad $15B ADC deal
biospace
Oct 19, 26
STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
stat
Oct 19, 26
Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study
biopharma dive
Oct 19, 26
Disc’s rebuffed rare disease drug sets up FDA redo after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Disc’s rebuffed rare blood disease drug sets up FDA re-do after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Veradermics’ minoxidil pill improves hair coverage in men in Phase 3
biospace
Oct 19, 26
Disc Medicine reports 'sun allergy' drug hits Phase 3 home run
endpoints
Oct 19, 26
TriGemX Bio is going public through SPAC to get its migraine prospect to market
endpoints
Oct 19, 26
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
biopharma dive
Oct 19, 26
STAT+: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
stat
Oct 19, 26
STAT+: How the No Surprises Act’s nonprofit arbitrators are operating like ‘mini gods’ and getting rich doing it
stat
Oct 19, 26
STAT+: Does Isomorphic Labs have what it takes to revolutionize drugmaking?
stat
Oct 19, 26
Disc spins past FDA rejection with ‘overwhelmingly positive’ phase 3 data for rare disease drug
fiercebiotech
Oct 19, 26
From cells to organoids: Cytokines that shape 3D culture
biospace
Oct 19, 26
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
biospace
Oct 19, 26
ESMO: Lilly touts 79% ADC response rate in competitive ovarian cancer space
fiercebiotech
Oct 19, 26
Should amylin have been obesity therapeutics’ primary target from the start?
biospace
Oct 19, 26
STAT+: Cambridge scientist David Sabatini speaks out after courtroom victory: ‘The hardest years of my life’
stat
Oct 17, 26
STAT+: Jury rules in favor of ousted Cambridge scientist David Sabatini, with $6 million in damages to be awarded
stat
Oct 16, 26
CHMP endorses Eli Lilly’s GLP-1 pill and three other new drugs
endpoints
Oct 16, 26
STAT+: RevMed’s pancreatic cancer drug nears European approval
stat
Oct 16, 26
What to read before you go see that new documentary on Elizabeth Holmes
stat
← prev
page 12 of 52
next →